Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Biological Gender in Peripheral Nerve Blockade
DRKS00030404Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine, sponsored by Medical University of Vienna. Started Jan 2023; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on DRKS00030404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00030404.